Skip to main content

Advertisement

Log in

Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren’s syndrome following immunosuppressive therapy

  • Case Report
  • Published:
Modern Rheumatology

Abstract

The patient described here is a 21-year-old Japanese woman with primary Sjögren’s syndrome (pSS) presenting with worsening of dyspnea, palpitation, recurrent parotitis, and arthritis. Chest computed tomography showed diffuse interlobular septal thickening and ground-glass opacities. Right heart catheterization demonstrated pulmonary hypertension, right-sided heart failure, normal pulmonary capillary wedge pressure, and no evidence of arterio-venous shunt. Transbronchial lung biopsy showed luminal obliteration of pulmonary venules by intimal cellular proliferations, without abnormalities in the small pulmonary arteries. These findings were consistent with pulmonary veno-occlusive disease (PVOD). Immunosuppressive therapy, starting with prednisolone 20 mg/day and subsequently combined with azathioprine, resulted in the disappearance of the signs and symptoms, including exertional dyspnea and abnormal pulmonary parenchymal shadows on computed tomography, and the normalization of pulmonary artery pressure. So far, there have been no reported cases of PVOD associated with pSS. Of interest, immunosuppressive therapy without vasodilator therapy almost completely resolved the pulmonary hypertension in this patient.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2

Similar content being viewed by others

References

  1. Watanabe M, Naniwa T, Hara M, Arakawa T, Maeda T. Pulmonary manifestations in Sjogren’s syndrome: correlation analysis between chest computed tomographic findings and clinical subsets with poor prognosis in 80 patients. J Rheumatol. 2010;37:365–73.

    Article  PubMed  Google Scholar 

  2. Launay D, Hachulla E, Hatron PY, Jais X, Simonneau G, Humbert M. Pulmonary arterial hypertension: a rare complication of primary Sjögren syndrome: report of 9 new cases and review of the literature. Medicine (Baltimore). 2007;86:299–315.

    Article  Google Scholar 

  3. Task Force for Diagnosis and Treatment of Pulmonary Hypertension of European Society of Cardiology (ESC); European Respiratory Society (ERS); International Society of Heart and Lung Transplantation (ISHLT), Galiè N, Hoeper MM, Humbert M, Torbicki A, Vachiery JL, Barbera JA, et al. Guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir J. 2009;34:1219–63.

    Google Scholar 

  4. Montani D, Achouh L, Dorfmüller P, Le Pavec J, Sztrymf B, Tchérakian C, et al. Pulmonary veno-occlusive disease: clinical, functional, radiologic, and hemodynamic characteristics and outcome of 24 cases confirmed by histology. Medicine (Baltimore). 2008;87:220–33.

    Article  Google Scholar 

  5. Jais X, Launay D, Yaici A, Le Pavec J, Tchérakian C, Sitbon O, et al. Immunosuppressive therapy in lupus- and mixed connective tissue disease associated pulmonary arterial hypertension: a retrospective analysis of twenty-three cases. Arthritis Rheum. 2008;58:521–31.

    Article  PubMed  Google Scholar 

  6. Sanchez O, Sitbon O, Jais X, Simonneau G, Humbert M. Immunosuppressive therapy in connective tissue diseases associated pulmonary arterial hypertension. Chest. 2006;130:182–9.

    Article  PubMed  CAS  Google Scholar 

  7. Sanderson JE, Spiro SG, Hendry AT, Turner-Warwick M. A case of pulmonary veno-occlusive disease responding to treatment with azathioprine. Thorax. 1977;32:140–8.

    Article  PubMed  CAS  Google Scholar 

  8. Hackman RC, Madtes DK, Petersen FB, Clark JG. Pulmonary venoocclusive disease following bone marrow transplantation. Transplantation. 1989;47:989–92.

    Article  PubMed  CAS  Google Scholar 

  9. Mandel J, Mark EJ, Hales CA. Pulmonary veno-occlusive disease. Am J Respir Crit Care Med. 2000;162:1964–73.

    PubMed  CAS  Google Scholar 

  10. Montani D, Price LC, Dorfmuller P, Achouh L, Jaïs X, Yaïci A, et al. Pulmonary veno-occlusive disease. Eur Respir J. 2009;33:189–200.

    Article  PubMed  CAS  Google Scholar 

  11. Dorfmüller P, Humbert M, Perros F, Sanchez O, Simonneau G, Müller KM, et al. Fibrous remodeling of the pulmonary venous system in pulmonary arterial hypertension associated with connective tissue diseases. Hum Pathol. 2007;38:893–902.

    Article  PubMed  Google Scholar 

  12. Wahidi MM, Rocha AT, Hollingsworth JW, Govert JA, Feller-Kopman D, Ernst A. Contraindications and safety of transbronchial lung biopsy via flexible bronchoscopy. A survey of pulmonologists and review of the literature. Respiration. 2005;72:285–95.

    Article  PubMed  Google Scholar 

  13. Cordasco EM Jr, Mehta AC, Ahmad M. Bronchoscopically induced bleeding. A summary of nine years’ Cleveland clinic experience and review of the literature. Chest. 1991;100:1141–7.

    Article  PubMed  Google Scholar 

  14. Schulman LL, Smith CR, Drusin R, Rose EA, Enson Y, Reemtsma K. Utility of airway endoscopy in the diagnosis of respiratory complications of cardiac transplantation. Chest. 1988;93:960–7.

    Article  PubMed  CAS  Google Scholar 

  15. Venables PJ. Sjögren’s syndrome. Best Pract Res Clin Rheumatol. 2004;18:313–29.

    PubMed  CAS  Google Scholar 

Download references

Acknowledgments

Special thanks to Dr. Shigeki Shimizu, Laboratory of Pathology, Toyama University Hospital, Toyama, Japan; and Dr. Yoshinori Kawabata, Division of Pathology, Saitama Cardiovascular Respiratory Centre, Kumagaya, Saitama, Japan, for the thoughtful discussion about the pathological diagnosis of this patient.

Conflict of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Taio Naniwa.

About this article

Cite this article

Naniwa, T., Takeda, Y. Long-term remission of pulmonary veno-occlusive disease associated with primary Sjögren’s syndrome following immunosuppressive therapy. Mod Rheumatol 21, 637–640 (2011). https://doi.org/10.1007/s10165-011-0440-9

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10165-011-0440-9

Keywords

Navigation